Neogen
NEOG
$12.14
Share price
1.51%
Change (1 day)
-29.13%
Change (1 year)
Neogen (NEOG) - P/B ratio
P/B ratio as of April 2024 : 0.8354
According to Neogen's latest financial reports the company has a price-to-book ratio of 0.8354.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Neogen - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.38 | 30.43% |
| 2022-12-31 | 1.06 | -81.26% |
| 2021-12-31 | 5.65 | 4.09% |
| 2020-12-31 | 5.43 | 9.09% |
| 2019-12-31 | 4.98 | 0.97% |
| 2018-12-31 | 4.93 | -19.16% |
| 2017-12-31 | 6.10 | 5.82% |
| 2016-12-31 | 5.76 | 2.93% |
| 2015-12-31 | 5.60 | -0.15% |
| 2014-12-31 | 5.61 | -5.5% |
| 2013-12-31 | 5.94 | 30.46% |
| 2012-12-31 | 4.55 | 28.19% |
| 2011-12-31 | 3.55 | -35.66% |
| 2010-12-31 | 5.52 | 47.1% |
| 2009-12-31 | 3.75 | 24.41% |
| 2008-12-31 | 3.01 | -19.5% |
| 2007-12-31 | 3.74 | 56.27% |
| 2006-12-31 | 2.40 | -17.59% |
| 2005-12-31 | 2.91 | -18.08% |
| 2004-12-31 | 3.55 | 2.43% |
| 2003-12-31 | 3.46 | 43.55% |
| 2002-12-31 | 2.41 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.67 | 459.48% | 🇺🇸 USA |
 Becton Dickinson BDX | 2.64 | 216.31% | 🇺🇸 USA |
 IDEXX Laboratories IDXX | 27.9 | 3,243.48% | 🇺🇸 USA |
 Illumina ILMN | 3.39 | 305.93% | 🇺🇸 USA |
 Danaher DHR | 3.41 | 308.48% | 🇺🇸 USA |
 PerkinElmer
PKI | 1.80 | 115.38% | 🇺🇸 USA |
 Pacific Biosciences
PACB | 0.5636 | -32.54% | 🇺🇸 USA |
 Meridian Bioscience VIVO | 4.05 | 384.18% | 🇺🇸 USA |